It's a huge problem. More than 230,000 Americans will be diagnosed with lung cancer this year. Almost all of them will receive chemotherapy. As crude as the existing guidelines are, says Kris, they won't be followed more than half the time. If we bumped up adherence by just 10% to 20%, he says, as many as 30,000 people might live longer. Never mind curing cancer -- shouldn't we be able to get the best available combinations of medications to sick people now?
That's the question that led Kris to IBM. He saw that more information was not the answer. What doctors needed was a better brain -- one that could instantly vacuum up facts, draw deeper connections between data points, and remember everything. They needed Watson.
|Buffett's annual letter: Learn from my real estate investments|
|What, me worry? Ukraine's officials seem to say|
|Julian Assange draws a big SXSW crowd, which quickly loses interest|
|Wal-Mart's 'neutral' stance on raising the minimum wage could hurt|
|Chart: Acquisitions by Apple, Amazon, Google, Yahoo, Facebook|